Internal Medicine, Hematology · Lexington, KY
NPI
1114452679
Since 2017
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Rose St Roach Cancer Ctr 1st Fl
Lexington, KY, 40536
Phone (859) 257-6006
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
526 services
Medicare patients, 2024
144
Average age 69
Drug cost, 2024
$3.5M
1,154 prescriptions
Company payments, 2025
$180
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fevzi F Yalniz was code 99233 (hospital e&m - subsequent), 275 times for 53 patients. In total Fevzi F Yalniz billed 526 services in 18 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 275 | 53 | $95.27 | $26K |
| 99215 Office E&M - Established | Facility | 91 | 50 | $109.73 | $9,985 |
| 99214 Office E&M - Established | Facility | 31 | 28 | $68.14 | $2,112 |
| 99222 Hospital E&M - Initial | Facility | 30 | 28 | $104.83 | $3,145 |
| 99223 Hospital E&M - Initial | Facility | 22 | 20 | $139.26 | $3,064 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 12 | $63.05 | $1,135 |
| 99205 Office E&M - New | Facility | 15 | 15 | $136.90 | $2,054 |
| 99239 Hospital Discharge Management | Facility | 13 | 12 | $91.87 | $1,194 |
By year: 2022 $19K for 213 services; 2023 $30K for 361 services; 2024 $51K for 526 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fevzi F Yalniz prescribed most often to Medicare patients was Acyclovir, with 167 prescriptions and refills. In total Fevzi F Yalniz wrote 1,154 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 167 | 189 | 47 | $2,748 |
| Venclexta Venetoclax | 58 | 58 | 17 | $190K |
| Prochlorperazine Maleate Generic | 39 | 41 | 21 | $590 |
| Levofloxacin Generic | 35 | 37 | 17 | $371 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 34 | 12 | $63.2 |
| Bosulif Bosutinib | 33 | 33 | Under 11 | $630K |
| Prednisone Generic | 32 | 38 | Under 11 | $94.85 |
| Brukinsa Zanubrutinib | 32 | 32 | Under 11 | $447K |
| Oxycodone Hcl Generic | 30 | 30 | Under 11 | $396 |
| Azithromycin Generic | 29 | 45 | Under 11 | $294 |
| Fluconazole Generic | 29 | 32 | 14 | $1,844 |
| Imatinib Mesylate Generic | 22 | 22 | Under 11 | $26K |
| Pantoprazole Sodium Generic | 20 | 30 | Under 11 | $238 |
| Cresemba Isavuconazonium Sulfate | 20 | 20 | Under 11 | $111K |
| Jakafi Ruxolitinib Phosphate | 20 | 20 | Under 11 | $302K |
Brand drugs: 332 claims; generic drugs: 822 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fevzi F Yalniz $180 ($180 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medexus Pharma, Inc. with $83.62.
| Company | Payments | Amount |
|---|---|---|
| Medexus Pharma, Inc. | 1 | $83.62 |
| Genzyme Corporation SNY | 1 | $73.18 |
| Stemline Therapeutics Inc. | 1 | $23.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.